Atlantic Health Clinical Research and Innovation Institute Receives Inaugural Endowment from Bruce I. Jacobs and Kenneth N. Levy to Advance Oncology Research

October 14, 2026: Atlantic Health announced a pledge of $5 million from Bruce Jacobs and Ken Levy aimed at accelerating novel research and discovery in oncology. The donation, in honor of the 40th anniversary of Jacobs Levy Equity Management, is the largest of its kind Atlantic Health has ever received in support of system-wide oncology research... “Thanks to the tireless spirit of giving and foresight of Bruce Jacobs and Ken Levy, this major endowment will provide Atlantic Health clinicians with the resources to pursue novel approaches to medicine and advance cancer care for communities well into the future,” said Saad Ehtisham, President and CEO, Atlantic Health. The Jacobs Levy Clinical Research and Innovation Endowment will generate annual income to provide a sustainable source of funding for the Atlantic Health Clinical Research and Innovation Institute. The endowment funds will be used for investigator-led studies, clinical trials, and research across several Atlantic Health sites, focused on improving patient outcomes in cancer care. Bruce said of the gift, “Our firm has long believed in the power of philanthropy to drive healthcare advances so it is immensely gratifying to know that this new endowment, as we commemorate four decades of pioneering investment research, will have a transformational impact on cancer care in New Jersey.” Ken added, “We’re proud to build on the long-standing relationship between our firm and Atlantic Health and the Foundation for Morristown Medical Center to support the deeply devoted clinicians, researchers and change agents at Atlantic Health.”

Building the Future of Quantitative Finance

by Ciaran Bellwoar, Wharton Magazine, Spring/Summer 2026: Bruce Jacobs is profiled in the Wharton Magazine cover story, tracing his interest in quantitative finance from his early fascination with stock price fluctuations to his transformational gift to the Wharton School to establish the Dr. Bruce I. Jacobs Master of Science in Quantitative Finance (MSQF) program... The article notes that Jacobs’s research contributions helped shape the emerging field of quantitative investing, and his influence will continue through his efforts to place Wharton at the forefront of educating future quants. Wharton faculty expressed their excitement about the MSQF program, “a pivotal moment made possible by Jacobs’s vision and a devotion to quantitative finance.” The article also highlights several Jacobs Scholars and how quantitative finance at Wharton has prepared them for success. Dean Erika James remarked, “We are immensely grateful to Bruce for his enduring support of quantitative finance research and educational opportunities at Wharton. His intellectual contributions to the field and impact on our students and scholars have been nothing short of game-changing.” Jacobs said, “I feel an obligation to ensure that future generations of Wharton students will have even greater opportunities to make an impact on the field of quantitative finance.”

Jacobs Levy Article Wins in the 27th Annual Bernstein Fabozzi/Jacobs Levy Awards

March 2, 2026: “How Misunderstanding Factor Models Set Unreasonable Expectations for Smart Beta” by Bruce Jacobs, Ken Levy, and Sangwoo Lee earned Outstanding Article recognition in the 27th Annual Bernstein Fabozzi/Jacobs Levy Awards. The winning articles were announced in the Multi-Asset Strategies and Asset Allocation 2026 issue of the Journal of Portfolio Management.... The awards were given for the best research articles appearing in the Journal of Portfolio Management in 2025, as chosen by subscribers. The award-winning article offers evidence that the poor performance of some smart beta strategies in recent years is due to shortcomings of standard factor pricing models, from which the strategies draw their well-known factors. Inevitably, these factors include some that may fall out of favor, sometimes for extended periods, as market conditions change. Smart beta strategies are also limited by the standard factor models’ narrow focus on a handful of generic factors and a failure to take into account correlations between factors. Overcoming these obstacles requires further steps toward a fully active, dynamic, multifactor approach, aka “smart alpha.”